New drug aims to shrink nasal polyps without surgery
NCT ID NCT07520162
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study tests a drug called tezepelumab in 230 Chinese adults with chronic sinusitis and nasal polyps. Participants receive injections every four weeks for six doses. Researchers will measure changes in polyp size and nasal congestion over 24 weeks to see if the treatment helps control the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tezepelumab (also called TEZSPIRE®)
- What this could lead to
- If successful, this could provide a new treatment option for Chinese adults with nasal polyps, reducing polyp size and easing congestion without surgery.
- What could go wrong
- This is an early-phase, single-arm study with no placebo group, so results may not prove the drug works better than no treatment. Side effects are possible, and the study is limited to Chinese participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGBeijing, 100034, China
-
Research Site
NOT_YET_RECRUITINGBeijing, 100191, China
-
Research Site
RECRUITINGBeijing, 100730, China
-
Research Site
NOT_YET_RECRUITINGBengbu, China
-
Research Site
RECRUITINGCangzhou, 061000, China
-
Research Site
NOT_YET_RECRUITINGChangchun, China
-
Research Site
RECRUITINGChangsha, China
-
Research Site
NOT_YET_RECRUITINGChangsha, China
-
Research Site
RECRUITINGChengdu, 610021, China
-
Research Site
NOT_YET_RECRUITINGChengdu, 610041, China
-
Research Site
NOT_YET_RECRUITINGChengdu, China
-
Research Site
NOT_YET_RECRUITINGChongqing, China
-
Research Site
RECRUITINGFoshan, 528000, China
-
Research Site
RECRUITINGFuzhou, 350005, China
-
Research Site
NOT_YET_RECRUITINGGuiyang, 550044, China
-
Research Site
NOT_YET_RECRUITINGHefei, 230601, China
-
Research Site
NOT_YET_RECRUITINGHefei, China
-
Research Site
NOT_YET_RECRUITINGHohhot, China
-
Research Site
RECRUITINGHuaian, 223300, China
-
Research Site
NOT_YET_RECRUITINGKunming, China
-
Research Site
RECRUITINGLanzhou, 730030, China
-
Research Site
RECRUITINGNanchang, China
-
Research Site
NOT_YET_RECRUITINGNanning, China
-
Research Site
RECRUITINGNingbo, China
-
Research Site
RECRUITINGQingdao, China
-
Research Site
NOT_YET_RECRUITINGShanghai, China
-
Research Site
NOT_YET_RECRUITINGShenyang, China
-
Research Site
RECRUITINGShenzhen, 518039, China
-
Research Site
NOT_YET_RECRUITINGShijiazhuang, 50051, China
-
Research Site
RECRUITINGTaiyuan, 030001, China
-
Research Site
RECRUITINGTaizhou, 225300, China
-
Research Site
RECRUITINGTianjin, China
-
Research Site
RECRUITINGÜrümqi, China
-
Research Site
NOT_YET_RECRUITINGWuhan, 430022, China
-
Research Site
NOT_YET_RECRUITINGWuhan, China
-
Research Site
RECRUITINGWuhu, 241004, China
-
Research Site
NOT_YET_RECRUITINGXi'an, 710004, China
-
Research Site
RECRUITINGYangzhou, 225000, China
-
Research Site
RECRUITINGZibo, 255036, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shrink nasal polyps and restore smell?
- Triple-Action nasal spray could ease chronic sinusitis
- 3D-Printed nose models could boost sinus rinse results
- Sinus surgery may ease sleep problems in nasal polyp patients
- Real-World check: do new biologics really help severe nasal polyps?
- New study digs into how mepolizumab changes nose bacteria and genes in asthma patients